Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionCwm, Llc
Latest Disclosed Ownership387 shares
Latest Disclosed Value $ 107,876
Cwm, Llc reports 51.17% increase in ownership of BIO / Bio-Rad Laboratories, Inc.

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 387 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $107,876 USD as of March 31, 2026. The current value of the position is $117,969 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIO RAD LABS CL A 090572207 387 131 51.17 108 0.0003
2026-01-26 2025-12-31 13F BIO RAD LABS CL A 090572207 256 54 26.73 0 0.0002
2025-10-15 2025-09-30 13F BIO RAD LABS CL A 090572207 202 91 81.98 0 0.0002
2025-07-25 2025-06-30 13F BIO RAD LABS CL A 090572207 111 -9 -7.50 0 0.0001
2025-05-01 2025-03-31 13F BIO RAD LABS CL A 090572207 120 -429 -78.14 0 0.0001
2025-02-04 2024-12-31 13F BIO RAD LABS CL A 090572207 549 -76 -12.16 0 0.0007
2024-10-08 2024-09-30 13F BIO RAD LABS CL A 090572207 625 -134 -17.65 0 0.0009
2024-07-10 2024-06-30 13F BIO RAD LABS CL A 090572207 759 103 15.70 0 0.0010
2024-04-05 2024-03-31 13F BIO RAD LABS CL A 090572207 656 100 17.99 0 0.0011
2024-02-01 2023-12-31 13F BIO RAD LABS CL A 090572207 556 -119 -17.63 0 0.0010
2023-10-11 2023-09-30 13F BIO RAD LABS CL A 090572207 675 107 18.84 0 0.0015
2023-08-03 2023-06-30 13F BIO RAD LABS CL A 090572207 568 201 54.77 0 0.0013
2023-05-01 2023-03-31 13F BIO RAD LABS CL A 090572207 367 -29 -7.32 0 0.0012
2023-02-01 2022-12-31 13F BIO RAD LABS CL A 090572207 396 31 8.49 0 -100.00 0.0012
2022-10-27 2022-09-30 13F BIO RAD LABS CL A 090572207 365 109 42.58 152 19.69 0.0012
2022-07-28 2022-06-30 13F BIO RAD LABS CL A 090572207 256 -52 -16.88 127 -26.59 0.0010
2022-04-21 2022-03-31 13F BIO RAD LABS CL A 090572207 308 113 57.95 173 17.69 0.0012
2022-01-31 2021-12-31 13F BIO RAD LABS CL A 090572207 195 45 30.00 147 51.55 0.0010
2021-09-15 2021-06-30 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2021-07-29 2021-06-30 13F BIO RAD LABS CL A 090572207 150 0 97 0.0008
2021-09-15 2021-03-31 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2021-04-27 2021-03-31 13F BIO RAD LABS CL A 090572207 135 -15 77 0.0007
2021-09-15 2020-12-31 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2021-01-27 2020-12-31 13F BIO RAD LABS CL A 090572207 83 -67 48 0.0004
2021-09-15 2020-09-30 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2020-10-19 2020-09-30 13F BIO RAD LABS CL A 090572207 87 -63 45 0.0005
2021-09-15 2020-06-30 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2020-07-22 2020-06-30 13F BIO RAD LABS CL A 090572207 54 -96 24 0.0003
2021-09-15 2020-03-31 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2020-04-28 2020-03-31 13F BIO RAD LABS CL A 090572207 54 -96 19 0.0003
2021-09-14 2019-12-31 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2020-01-27 2019-12-31 13F BIO RAD LABS CL A 090572207 109 -41 40 0.0005
2021-09-14 2019-09-30 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2019-10-22 2019-09-30 13F BIO RAD LABS CL A 090572207 102 -48 34 0.0005
2021-09-14 2019-06-30 13F/A-1 BIO RAD LABS CL A 090572207 150 0 0.00 97 0.00 0.0008
2019-07-31 2019-06-30 13F BIO RAD LABS CL A 090572207 102 -48 32 0.0005
2021-09-02 2019-03-31 13F/A-1 BIO RAD LABS CL A 090572207 150 48 47.06 97 304.17 0.0008
2019-04-22 2019-03-31 13F BIO RAD LABS CL A 090572207 102 0 31 0.0006
2019-01-25 2018-12-31 13F BIO RAD LABS CL A 090572207 102 72 240.00 24 166.67 0.0006
2018-10-29 2018-09-30 13F BIO RAD LABS CL A 090572207 30 0 0.00 9 0.00 0.0002
2018-07-31 2018-06-30 13F BIO RAD LABS CL A 090572207 30 30 9 0.0003
2018-01-16 2017-12-31 13F BIO RAD LABS CL A 090572207 0 -12 -100.00 0 -100.00
2017-10-16 2017-09-30 13F BIO RAD LABS CL A 090572207 12 0 0.00 3 0.00 0.0001
2017-07-17 2017-06-30 13F BIO RAD LABS CL A 090572207 12 0 0.00 3 50.00 0.0002
2017-04-17 2017-03-31 13F BIO RAD LABS CL A 090572207 12 0 0.00 2 0.00 0.0001
2017-01-19 2016-12-31 13F BIO RAD LABS CL A 090572207 12 12 2 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.